As Axogen (AXGN) Stock Value Rose, Opaleye Management Decreased Stake; As Ctrip Com Intl LTD (CTRP) Stock Price Declined, Shareholder Marsico Capital Management Has Trimmed Its Stake by $2.49 Million

August 12, 2018 - By Billy Entrekin

AxoGen, Inc. (NASDAQ:AXGN) Logo

Marsico Capital Management Llc decreased its stake in Ctrip Com Intl Ltd (CTRP) by 18.1% based on its latest 2018Q1 regulatory filing with the SEC. Marsico Capital Management Llc sold 54,225 shares as the company’s stock declined 1.25% with the market. The institutional investor held 245,298 shares of the miscellaneous company at the end of 2018Q1, valued at $11.44M, down from 299,523 at the end of the previous reported quarter. Marsico Capital Management Llc who had been investing in Ctrip Com Intl Ltd for a number of months, seems to be less bullish one the $21.81B market cap company. The stock decreased 1.01% or $0.41 during the last trading session, reaching $40. About 3.78 million shares traded. Ctrip.com International, Ltd. (NASDAQ:CTRP) has declined 16.53% since August 12, 2017 and is downtrending. It has underperformed by 29.10% the S&P500. Some Historical CTRP News: 19/03/2018 – CTRIP, ROYAL CARIBBEAN CRUISES TO END SKYSEA JV; 11/04/2018 – CEO of Ctrip Jane Sun meets the First Minister of Scotland; 14/03/2018 – CTRIP SEES 1Q REV. +9% TO +11%; 22/05/2018 – CTRIP 1Q ADJ. EARNINGS PER ADS 55C, EST. $1.00; 14/03/2018 – CTRIP 4Q ADJ EARNINGS PER ADS 24C, EST. 17C; 02/04/2018 – Ctrip Named Silkroad’s Official Sponsor and Exclusive Travel Services Provider; 18/05/2018 – Ctrip Participates in Annual Travel Show 2018 ITB China; 22/05/2018 – CTRIP.COM INTERNATIONAL LTD – QTRLY DILUTED EARNINGS PER ADS WERE RMB1.81 (US$0.29); 15/05/2018 – DUQUESNE REDUCED MSFT, CTRP, WDAY, STMP, NKTR IN 1Q: 13F; 11/04/2018 – Consolidated Research: 2018 Summary Expectations for Ctrip.com International, JA Solar Holdings, Co., Oaktree Specialty Lending

Opaleye Management Inc decreased its stake in Axogen Inc (AXGN) by 12.94% based on its latest 2018Q1 regulatory filing with the SEC. Opaleye Management Inc sold 255,000 shares as the company’s stock rose 53.73% while stock markets declined. The hedge fund held 1.72M shares of the health care company at the end of 2018Q1, valued at $62.60 million, down from 1.97M at the end of the previous reported quarter. Opaleye Management Inc who had been investing in Axogen Inc for a number of months, seems to be less bullish one the $1.47 billion market cap company. The stock decreased 2.41% or $0.95 during the last trading session, reaching $38.45. About 271,310 shares traded. AxoGen, Inc. (NASDAQ:AXGN) has risen 194.48% since August 12, 2017 and is uptrending. It has outperformed by 181.91% the S&P500. Some Historical AXGN News: 09/05/2018 – AxoGen, Inc. Announces Upsizing and Pricing of Public Offering of Common Stk; 12/04/2018 – AxoGen, Inc. Announces 2018 Annual Shareholders’ Meeting; 15/05/2018 – Arrowmark Partners Buys New 3.4% Position in AxoGen; 21/05/2018 – AxoGen at JMP Securities Life Sciences Conference Jun 20; 12/04/2018 – AxoGen, Inc. Announces 2018 Annual Shareholders’ Meeting; 09/05/2018 – AXOGEN SEES GROSS PROCEEDS OF ABT $123M; 30/04/2018 – AxoGen 1Q Loss/Shr 16c; 21/04/2018 – DJ AxoGen Inc, Inst Holders, 1Q 2018 (AXGN); 14/05/2018 – AxoGen, Inc. Announces Closing of Public Offering of Common Stk; 30/04/2018 – AxoGen Sees 2018 Revenue Up at Least 40%

Among 8 analysts covering AxoGen (NASDAQ:AXGN), 8 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. AxoGen had 24 analyst reports since August 11, 2015 according to SRatingsIntel. On Monday, August 21 the stock rating was maintained by Cantor Fitzgerald with “Buy”. The stock of AxoGen, Inc. (NASDAQ:AXGN) has “Buy” rating given on Tuesday, November 22 by Lake Street. The rating was maintained by Roth Capital on Monday, September 11 with “Buy”. The stock has “Buy” rating by Leerink Swann on Tuesday, June 26. On Wednesday, February 28 the stock rating was maintained by Cantor Fitzgerald with “Buy”. On Thursday, March 1 the stock rating was maintained by JMP Securities with “Market Outperform”. Lake Street downgraded the stock to “Hold” rating in Thursday, November 3 report. The rating was maintained by Wedbush with “Buy” on Tuesday, November 21. Cantor Fitzgerald maintained AxoGen, Inc. (NASDAQ:AXGN) on Tuesday, May 1 with “Overweight” rating. As per Friday, March 2, the company rating was maintained by Lake Street.

Opaleye Management Inc, which manages about $151.96 million and $349.75M US Long portfolio, upped its stake in Amarin Corp Plc (NASDAQ:AMRN) by 885,000 shares to 1.75M shares, valued at $5.25 million in 2018Q1, according to the filing. It also increased its holding in Quanterix Corp by 85,000 shares in the quarter, for a total of 150,000 shares, and has risen its stake in Achillion Pharmaceuticals Inc (NASDAQ:ACHN).

More important recent AxoGen, Inc. (NASDAQ:AXGN) news were published by: Nasdaq.com which released: “AxoGen, Inc. Reports 2018 Second Quarter Financial Results” on August 01, 2018, also 247Wallst.com published article titled: “5 Incredible Stocks to Buy Now That Wall Street Ignores”, Fool.com published: “Here’s Why AxoGen, Inc. Fell as Much as 18.6% Today” on August 02, 2018. More interesting news about AxoGen, Inc. (NASDAQ:AXGN) was released by: Globenewswire.com and their article: “AxoGen, Inc. to Present at Canaccord Genuity Growth Conference” with publication date: July 25, 2018.

Analysts await AxoGen, Inc. (NASDAQ:AXGN) to report earnings on November, 7. They expect $-0.06 earnings per share, 0.00% or $0.00 from last year’s $-0.06 per share. After $-0.14 actual earnings per share reported by AxoGen, Inc. for the previous quarter, Wall Street now forecasts -57.14% EPS growth.

Analysts await Ctrip.com International, Ltd. (NASDAQ:CTRP) to report earnings on August, 29. They expect $0.09 EPS, 0.00% or $0.00 from last year’s $0.09 per share. CTRP’s profit will be $49.07 million for 111.11 P/E if the $0.09 EPS becomes a reality. After $0.45 actual EPS reported by Ctrip.com International, Ltd. for the previous quarter, Wall Street now forecasts -80.00% negative EPS growth.

Among 26 analysts covering Ctrip.com International Ltd. (NASDAQ:CTRP), 19 have Buy rating, 0 Sell and 7 Hold. Therefore 73% are positive. Ctrip.com International Ltd. had 58 analyst reports since August 6, 2015 according to SRatingsIntel. Oppenheimer maintained Ctrip.com International, Ltd. (NASDAQ:CTRP) rating on Wednesday, August 5. Oppenheimer has “Outperform” rating and $95 target. The rating was initiated by Bernstein on Wednesday, January 11 with “Mkt Perform”. The stock of Ctrip.com International, Ltd. (NASDAQ:CTRP) has “Buy” rating given on Wednesday, September 23 by Credit Agricole. The firm has “Outperform” rating given on Friday, September 2 by Credit Suisse. The stock of Ctrip.com International, Ltd. (NASDAQ:CTRP) earned “Buy” rating by Summit Research on Monday, September 21. Brean Capital maintained the stock with “Buy” rating in Thursday, June 16 report. The firm has “Buy” rating by Cowen & Co given on Thursday, March 15. The stock of Ctrip.com International, Ltd. (NASDAQ:CTRP) has “Buy” rating given on Monday, August 10 by Zacks. TH Capital downgraded Ctrip.com International, Ltd. (NASDAQ:CTRP) on Monday, February 26 to “Hold” rating. The firm has “Buy” rating by Oppenheimer given on Thursday, August 24.

Marsico Capital Management Llc, which manages about $17.14B and $2.66 billion US Long portfolio, upped its stake in Adobe Sys Inc (NASDAQ:ADBE) by 159,846 shares to 242,309 shares, valued at $52.36M in 2018Q1, according to the filing. It also increased its holding in Norwegian Cruise Line Hldgs (NASDAQ:NCLH) by 96,863 shares in the quarter, for a total of 333,017 shares, and has risen its stake in Dominos Pizza Inc (NYSE:DPZ).

Another recent and important Ctrip.com International, Ltd. (NASDAQ:CTRP) news was published by Nasdaq.com which published an article titled: “Chinese Stocks: Are They Finally Cheap?” on July 26, 2018.

Ctrip.com International, Ltd. (NASDAQ:CTRP) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts